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Abstract
The h-barrel is a transmembrane structural motif commonly encountered in bacterial outer membrane proteins and pore-forming toxins
(PFTs). a-Hemolysin (aHL) is a cytotoxin secreted by Staphylococcus aureus that assembles from a water-soluble monomer to form a
membrane-bound heptameric h-barrel on the surface of susceptible cells, perforating the cell membranes, leading to cell death and lysis. The
mechanism of heptamer assembly, which has been studied extensively, occurs in a stepwise manner, and the structures of the initial,
monomeric form and final, membrane-embedded pore are known. The toxin’s ability to assemble from an aqueous, hydrophilic species to a
membrane-inserted oligomer is of interest in understanding the assembly of PFTs in particular and the folding and structure of h-barrel
membrane proteins in general. Here we review the structures of the monomeric and heptamer states of LukF and aHL, respectively, the
mechanism of toxin assembly, and the relationships between aHL and nontoxin h-barrel membrane proteins.
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There are two structural classes of transmembrane pro-
teins: a-helical and h-barrel. The a-helical motif is most
often found in the receptors and ion channels of plasma and
endoplasmic reticulum membranes. Information about the
folding of a-helical membrane proteins has largely been
provided from studies of bacteriorhodopsin (reviewed in
Ref. [1]). There is a growing understanding of the folding
process in the field of h-barrel membrane protein study,
although progress has been slower than with a-helical
membrane proteins. The h-barrel is most often encountered
in membrane proteins that reside in the outer membrane of
Gram-negative bacteria and in the mitochondrial membrane
and it is a motif used by many bacterial pore-forming toxins
(PFTs) to form cytotoxic transmembrane channels.
PFTs form hydrophilic pores in the cytoplasmic mem-
branes of target cells. These toxins require multiple copies
of the protein molecules to form an oligomeric pore. The
proteins are released by the bacteria as water-soluble species
and subsequently bind to susceptible membranes. Mem-
brane binding increases the local concentration of toxin and
triggers conformational changes, thus facilitating the oligo-
merization process. Toxin oligomerization leads to insertion
into the membrane and formation of a protein-lined pore
ranging in diameter from 1 to 2 nm for Staphylococcal a-
hemolysin (aHL) [2] and Vibrio cholerae cytolysin [3], and
from 15 to 25 nm for streptolysin O [4] and perfringolysin O
[5].
The family of PFTs can be divided into two types: the a-
PFTs, which form pores by the insertion of amphipathic a-
helices, and the h-PFTs, which form pores by the insertion
of amphipathic h-hairpins to create a h-barrel. In both types
of PFTs, the hydrophilic side of the protein faces the
aqueous environment of the pore while the hydrophobic
surface faces the acyl chains of the membrane bilayer. The
h-PFTs can be further divided into two subtypes, the first of
which forms pores and disrupts cell membranes, compro-
mising cell permeability and leading to cell lysis, as exem-
plified by aHL; the second subtype consists of the A–B
toxins, where the B subunits form oligomeric complexes for
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the purpose of delivering the catalytic A portion of the toxin
to the cytosol of the target cell, as in the case of the anthrax
toxin complex. The A protein moieties of anthrax toxin,
lethal factor and edema factor, translocate across endosomal
membranes after insertion and pore formation of the B
moiety, protective antigen (PA). PA forms homoheptameric
A 1 2 3
1A2A1
4
7
12
14
16
16
14 15 15
B C D 13
7"
8
8
9 10 11
9
5 5 6
7'6
Fig. 1. Alignment of the sequences of aHL, g-hemolysin (HlgB and HlgC) and Luk (LukF-PV and LukE) proteins. Secondary structure elements of aHL
(upper) and structural elements unique to the water-soluble, monomeric form of LukF (lower) are displayed above the sequences. The sequence numbering is
for aHL. Residues with a black background are identical in half or more of the sequences, whereas residues with a grey background are conservative
substitutions in half or more of the sequences. ClustalW was used to perform the alignment and Boxshade 3.21 was used to create the figure.
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pores [6] composed of a 14-strand h-barrel. A disordered
loop present in the water-soluble structure of PA shares
sequence characteristics with the pore-forming region of
aHL and it has been suggested that the PA pore assembly
mechanism is similar to that proposed for aHL [7].
aHL is a h-PFT produced by Staphylococcus aureus.
Along with the PFTs g-hemolysin (gHL) and leukocidin
(Luk), aHL is one of many toxins secreted by S. aureus
during the postexponential phase of the bacterium’s growth
[8,9]. The biologically active state of aHL is a membrane-
embedded homoheptameric pore that forms from the assem-
bly of secreted water-soluble monomers on the target cell
membrane. Of all the PFTs, it is the best understood
structurally, as both endpoints of its assembly process are
known.
gHL and Luk are bicomponent h-PFTs related in amino
acid sequence and function to aHL [10]. A functional Luk
pore is formed from a heterooligomeric complex of class F
and class S protomers in f 1:1 ratio [11]. The subunit
stoichiometry for Luk is still under debate, with model
building and experimental data being marshalled to suggest
either heptameric [12] or octameric [13] stoichiometries.
There are five classes of F proteins and six classes of S
proteins, allowing for 30 possible binary combinations [14].
HgII, a class S subunit, can also combine with class F
proteins to form gHL [9]. The F and S proteins are 70%
identical within a class, whereas the sequence identity
between classes falls to f 30%. The class F proteins are
more closely related in sequence to aHL (f 30% identity)
than the S proteins (f 20% identity) (Fig. 1) [15]. Despite
the difference in sequence identity, the aHL protomer core
is very similar in structure to the class F proteins LukF and
LukF-PV [15,16], and, we predict, the remaining class F and
class S proteins. aHL and the bicomponent toxins have
similar molecular weights and isoelectric points, core hydro-
phobic residues, and a glycine-rich region located in the
middle of the primary sequence [10].
1. Structures
The structure of the heptameric, active form of aHL has
been determined in the presence of detergent micelles [17].
Early characterization of the hemolysin oligomer suggested
a hexameric subunit stoichiometry [18–21]. Initial crystal-
lographic analysis, in which a seven-fold axis of rotational
or screw axis symmetry was discovered [22], suggested that
the assembled pore was a heptamer with a seven-fold axis of
rotational symmetry. The crystallographic studies, in com-
bination with high-resolution electrophoretic analysis of
erythrocyte-assembled toxins, reinforced the conclusion that
the aHL oligomer was a heptamer [23]. More recent studies,
including atomic force microscopy (AFM) performed on
prepore intermediates [24,25] and single-channel conduc-
tance experiments using SH modification of an aHL cys-
teine mutant [26], as well as the crystal structure [17],
confirm the heptameric arrangement of the assembled pore.
Under some conditions, the results of AFM experiments
suggest that aHL oligomers with a hexameric stoichiometry
may also be found [27].
The protein complex is mushroom shaped with overall
dimensions of 100 A˚ 100 A˚ (Fig. 2). The seven-fold
noncrystallographic axis of symmetry runs parallel to the
channel opening, which spans the entire length of the
protein assemblage. At its widest and narrowest points,
the channel diameter is 46 and 14 A˚, respectively. The
overall architecture of the protein is divided into three
domains: the cap, rim and stem. The ca. 48-A˚-high cap
domain is largely hydrophilic and, with the rim domain,
projects from the extracellular surface of the membrane,
corresponding to protrusions on lipid membranes viewed by
electron microscopy [21]. The cap is composed of seven h
sandwiches and amino latches from each protomer. The rim
domain lies on the underside of the cap and forms a three-
strand h sheet. It is in close proximity and/or direct contact
with the outer leaflet of the membrane bilayer. The stem
domain is formed by a 14-strand anti-parallel h-barrel,
defining the transmembrane portion of the channel. Each
protomer contributes two strands to the barrel. The stem is
52 A˚ high and 26 A˚ (Ca–Ca) wide.
The protomer core has a kidney-shaped structure that is
70 A˚ tall along the seven-fold axis and is 45 A˚ thick and 20
A˚ wide [17]. An individual protomer consists of a 5 + 6 h
sandwich connected continuously to the rim domain com-
posed of three h strands and non-a, non-h structure,
forming the protein core. Two prominent structural features
that extend from the core are the amino latch (residues A1–
V20), which makes extensive contacts with an adjacent
protomer, and the glycine-rich h-strands 7 and 8 (residues
K110–Y148), which form the stem domain. The amino
latch and glycine-rich stem domains undergo considerable
conformational changes during the course of heptamer
assembly. The triangle region, formed by residues D103 to
T109 and V149 to D152, connects the stem domain to the
h-sandwich core. This region participates in key interpro-
tomer interactions in neighboring triangle and rim domains.
The structure of the heptamer revealed, at high resolu-
tion, the architecture of the assembled toxin pore. Circular
dichroism (CD) experiments showed that the water-soluble
monomer and assembled pore had largely h-sheet structures
with similar CD spectra, suggesting that there is little
change in the net secondary structure composition of the
protein during the assembly process [19,20]. Nevertheless,
there was abundant evidence to suggest that major confor-
mational changes occurred along the toxin assembly path-
way [19,20,28–30]. The crystal structures of the water-
soluble form of two class F Luk proteins have helped to
elucidate the structural changes occurring as the toxin
assembles to form the transmembrane pore.
The structures of the Luk F component HlgB (LukF) and
the Panton-Valentine Luk F component (LukF-PV) have
been determined [15,16]. The amino acid sequences of these
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class F proteins share 72% identity and their three-dimen-
sional structures are very similar. Superposition of the
structures gives a root-mean-square difference of 1.0 A˚ for
292 out of 301 Ca atoms, with the major deviations
occurring in the loop regions and at the N and C termini
[31]. The core of the secreted monomers is very similar to
the aHL protomer (Fig. 2). The h sandwich is composed of
2 six-strand anti-parallel h sheets. The rim domain extends
underneath the h sandwich and the orientation of the two
domains with respect to each other is the same in LukF and
LukF-PV. However, an 11j to 15j rotation is needed to
superimpose the rim domains of a soluble monomer and an
aHL protomer after superposition of the h-sandwich
domains. It is not clear whether this is due to the difference
in sequence or assembly state. The axis about which this
rotation occurs is located at the interface between the two
domains [15,16,31].
In addition to this difference in relative domain orienta-
tion, there are two striking structural differences between the
aHL protomer and the soluble proteins. The amino latch,
Fig. 2. Ribbon representation of the aHL heptamer viewed perpendicular to (A) and along the seven-fold axis of symmetry (B). Each protomer is a different
color. The cap, rim, and stem domains are labeled. The heptamer is approximately 100 A˚ tall and measures 100 A˚ at its widest point. The channel ranges in
diameter from 14 to 46 A˚. The hydrophobic, transmembrane portion of the assembled pore is approximately 28 A˚ thick. The LukF monomer (C) and a
protomer removed from the aHL heptamer (D) are shown in ribbon representation with predicted binding to the membrane and the amino latch, h-sandwich,
triangle, (pre-)stem, and rim domains labeled.
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residues 1–12 in the water-soluble LukF proteins, adopts a
h conformation, adjoining the inner h sheet of the h
sandwich [15,16]. In contrast, the amino latch of the aHL
protomer has non-a, non-h structure with one turn of a 310
helix and forms both polar and nonpolar contacts with the
inner h sheet of its neighboring protomer [17]. It is possible
that the amino latches of aHL and LukF have different
conformations in their respective oligomers. The stem
domain, which contributes two extended h strands to the
transmembrane pore in aHL, has a dramatically different
and compact folded conformation in the monomer structure,
referred to as the prestem. This prestem domain, comprising
residues 110–144 in LukF, forms a three-strand anti-parallel
h sheet that packs against the h-sandwich core through
hydrophobic van der Waals contacts [15]. The fold of the
domain is topologically related to a family of snake venom
toxins [16]. In LukF, portions of this glycine-rich region are
disordered, and in the water-soluble aHL monomer, this
region is protease accessible, suggesting that this domain is
highly flexible in the water-soluble form of the toxin.
2. Membrane contacts
Direct rim domain interactions with the lipid headgroups
of the membrane bilayer are suggested by the close prox-
imity of the rim’s base to the transmembrane region of the
stem domain. Co-crystals of the aHL heptamer with dihep-
tanoyl phosphatidylcholine demonstrate association of the
lipid in the crevice between the tip of the stem domain and
the rim domain [17]. A similar binding site was observed for
the LukF monomer co-crystallized with dipropanoyl phos-
phatidylcholine [15], and the choline-like buffer MES was
found associated in the same position in the LukF-PV
crystal structure [16]. Fluorescence changes on binding of
an acrylodan-labeled single cysteine mutant at position 266
[28] and spectroscopic probes of conformational changes in
the toxin upon membrane binding and insertion [32] support
the idea that the rim domain is in contact with the lipid
bilayer. The surface of the rim domain of aHL has numer-
ous solvent-exposed aromatic residues (Y68, W179, Y182,
W187, W190, W260, W265, W274; see Fig. 3) [33], with
six of the eight tryptophans localized to the rim surface.
Intrinsic tryptophan fluorescence emission (ITFE) studies
show that Trp contacts with the hydrophobic membrane
environment account for increases in ITFE [34,35] for
membrane-bound aHL as compared to the water-soluble
monomer.
Before the aHL structure determination, Valeva et al.
[28,36,37] and Ward et al. [30] had demonstrated that
residues 126–140 in the stem domain participate in forming
the transmembrane pore. Both ends of the stem are ringed
with polar and charged residues, whereas the intervening
residues form an uncharged band that lines the stem exterior.
This hydrophobic belt is defined at its top by a ring of
aromatic amino acids formed by Y118 and F120 (Fig. 3)
and at its bottom by G126 [17]. The nonpolar belt interacts
with the nonpolar portion of the bilayer, and is thick enough
(f 28 A˚) to span the hydrophobic portion of the erythro-
cyte bilayer. On the basis of three-dimensional structures of
membrane proteins and studies of transmembrane model
Fig. 3. Ribbon representation of four protomers from the heptamer
structure, viewed perpendicular to the seven-fold axis of noncrystallo-
graphic symmetry. In (A), polar residues that have been implicated in
binding [44] are shown in violet and ball-and-stick representation. The
hydrophobic belt formed by residues Y118 and F120 is highlighted in
yellow ball-and-stick representation. The abundance of aromatic residues
found in the rim domain is illustrated in (B), with tryptophans and tyrosines
drawn in orange ball-and-stick representation.
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peptides, it appears that the aliphatic side chains of un-
charged amino acids prefer the lipid hydrocarbon chains,
the aromatic residues favor the lipid carbonyl portion of the
bilayer, and the polar residues interact with the charged
lipid headgroups [38]. This transmembrane residue organ-
ization is consistent with the observed arrangement of
residues in the aHL pore. The interaction of distinct
membrane environments with complementary transmem-
brane segments certainly must play an important role in
folding and in defining the final position of the trans-
membrane pore in the perforated bilayer [39].
3. Mechanism of assembly
A wealth of biochemical and genetic data support the
mechanism of aHL assembly illustrated in Fig. 4 [29,40].
aHL is secreted as a water-soluble monomer (a1). Upon
binding to the membrane of a susceptible cell, the mem-
brane-bound monomer (a1*) assembles to a membrane-
embedded heptamer (a7) via a nonlytic heptameric prepore
(a7*). The high affinity with which aHL binds to sensitive
cells, such as rabbit erythrocytes, suggests that membrane
binding is receptor mediated, but a receptor remains to be
identified. The membrane-embedded heptamer creates a
water-filled channel in the bilayer, leading to a disruption
of the cellular chemiosmotic balance and finally, if a
sufficient number of toxins pierce the bilayer, cell lysis.
The water-soluble monomer is sensitive to trypsinolysis.
The two susceptible trypsin cleavage sites are at Lys8 in the
N-terminal amino latch and Lys131 in the glycine-rich
region. The proteolytic accessibility of the glycine-rich
region coincides with an area of disorder observed in the
LukF structure [15], suggesting that the prestem is flexible
and solvent exposed in the water-soluble form of the toxin.
An amino-terminal truncation mutant, aHL (A3–293) was
accessible to proteolysis near the N terminus [29]. This
mutant was retarded in the rate of oligomerization, allowing
for the observation of monomeric and oligomeric states that
were resistant to cleavage in the glycine-rich region when
bound to the surface of a rabbit erythrocyte, and it was also
deficient in pore formation. Membrane binding may occlude
the proteolysis sites located in the glycine-rich loop, hinder-
ing the ability of proteolytic enzymes to cleave at these
locations. Through the use of site-directed mutants that are
unable to form membrane-inserted channels, it was
observed that the heptameric prepore remains sensitive to
trypsin at the N terminus [23] and can be dissociated to
monomers by sodium dodecyl sulfate (SDS) at room tem-
perature. In contrast, the fully assembled heptamer is SDS
insensitive at temperatures up to 65 jC and is remarkably
resistant to trypsin-mediated proteolysis.
A series of experiments using single-cysteine replace-
ment mutants in conjunction with fluorescent probes has
been used to study the membrane insertion event. The
fluorescence studies using acrylodan-labeled cysteine
mutants have shown that residues 118–140 within the
glycine-rich loop move from a hydrophilic to a hydrophobic
environment upon pore formation [28,36]. This transition
occurs only after toxin oligomerization on membranes and
corresponds to the protein inserting into the membrane. The
prepore to pore transition is a cooperative process; experi-
ments using hybrid oligomers composed of active and
functionally deficient toxin monomers showed that inactive
subunits were able to suppress the membrane-penetrating
action of active subunits [28]. The transition from prepore to
assembled heptamer may occur in a series of substates
(a7*a,b,c) [41], with evidence suggesting that intraprotomer
communication between an amino latch and prestem may
activate the prestem for membrane insertion, and that an
Fig. 4. Mechanism of aHL assembly. The structure for LukF (1), drawn in ribbon representation, represents the water-soluble form of the toxin. The
membrane-bound monomer (2) and prepore (3) are drawn in cartoon, as their structures are unknown, although the fold of the protomer core is almost certainly
preserved. The assembled heptamer (4) is drawn in ribbon representation. The protomer cores are blue and the amino latches (pink) and glycine-rich prestem
(monomer and prepore states) and stem (heptamer) domains (orange) are also shown.
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activated prestem may activate other prestem loops within
the prepore [42]. Deletions at the N terminus [29,43] and
mutations within the glycine-rich region [44,45] yielded
nonlytic heptamers, indicating that these areas play impor-
tant roles in the transition from heptameric prepore to
assembled pore.
4. h-Barrel membrane protein folding
For membrane proteins, and particularly for h-barrel
membrane proteins, progress has lagged in establishing the
fundamental principles of folding and structure. Some of
the better studied h-barrel membrane proteins are the outer
membrane proteins (Omps) (reviewed in Ref. [46]), and
the best examined of these in terms of folding mechanism
is OmpA. Structural and kinetic studies performed using
the transmembrane domain of OmpA [47–49] have
resulted in a model for the insertion and folding of OmpA
in the outer membrane. The insertion and folding reaction
occurs spontaneously without the need of accessory pro-
teins. In the aqueous phase, OmpA is unstructured and
encounters the membrane in this state. Upon membrane
association, a molten disc is formed, a membrane-bound
intermediate localized at the interfacial region of the
bilayer composed of single or paired h-strands dynamic
and metastable hydrogen-bonding contacts. Subsequent to
this stage, an inside-out molten globule is formed, having
some of the characteristics of h-barrels. The native struc-
ture is achieved only after an extensive amount of rear-
rangement for proper side-chain contacts and backbone
hydrogen bonding between strands [49]. The molten disc
described here may be analogous to the prepore intermedi-
ate of aHL. For both proteins, the membrane insertion
process is the rate-limiting step, most likely because of the
side chain and secondary structure rearrangements required
for pore formation. The major difference between the two
assemblages lies in the fact that OmpA inserts its entire
polypeptide chain into the membrane to form its pore,
whereas aHL maintains a stable core structure, which is
defined by the h-sandwich and rim domains, and inserts
only a small portion of its seven protomers to form the
transmembrane channel.
White et al. have developed a model system for exami-
nation of the thermodynamic and structural parameters of h-
strand folding in the membrane [39,50–53]. Using small
model peptides, they have calculated the cost of peptide
bond partitioning into nonpolar phases (partitioning–fold-
ing coupling) [53]. After observing the cooperative h-sheet
formation of hydrophobic peptides in lipid bilayers, they
suggest that secondary structure formation is driven by
hydrogen bonding, which reduces the free energy of peptide
bond partitioning [52]. For aHL, which buries f 154
residues in the membrane during pore formation, the total
effect on the lowering of free energy would be great, and
may help explain why pore formation for the toxin is
essentially irreversible. If interstrand backbone hydrogen
bonds drive and stabilize h-sheet formation [50], then the
side chains are left to form favorable interactions with the
membrane bilayer. This supports the observed requirement
for nonpolar residues in the transmembrane regions of h-
barrel membrane proteins.
5. Applications
aHL has been used for a range of applications in the
bioengineering field. Studies have focused on manipulating
pore assembly from monomers and on manipulating proper-
ties of fully assembled pores. It has been possible to control
aHL assembly using chemical, physical, and biochemical
agents. Placement of a pentahistidine sequence in the
glycine-rich loop creates an assembled pore with channel
currents modulated by metal ions [54]. The currents can be
switched ‘off’ by the addition of Zn2 +, for example, and can
be turned ‘on’ with the addition of the zinc-chelating
reagent ethylenediaminetetraacetic acid (EDTA). A pro-
tease-activated aHL was made using complementary muta-
genesis [55], in which aHL proteins were produced with
redundant, protease-sensitive sequences in the glycine-rich
stem domain. These duplicate sequences prevented pore
formation, but proteolytic removal of the redundancies
activated channel insertion. Light has also been used as a
trigger for pore formation. Light-sensitive sulfhydryl
reagents were used to block the hemolytic activity of
single-cysteine aHL mutants and hemolytic activity was
restored after UV irradiation regenerated the sulfhydryl
group [56].
The crystal structure of the heptamer has aided in
engineering the properties of the fully assembled pore.
When equipped with a noncovalently bound adapter mol-
ecule that mediates channel blocking by small molecule
analytes, aHL can work as a stochastic sensor [57]. One of
the adapter molecules, h-cyclodextrin (hCD), is a cyclic
molecule comprised of seven D-glucose units that binds to
the lumen of the assembled pore and is able to accom-
modate small ‘guest’ molecules or analytes. Because
different analytes have characteristic residence times and
cause a particular degree of channel blocking mediated by
hCD, it is possible to detect specific analytes in a single-
channel recording system. Single-stranded (ss) DNA and
RNA have also been detected using single-channel con-
ductance measurements of an aHL pore. Akeson et al. [58]
used the toxin channel to analyze the composition and
linear sequences within a single ssRNA polymer on the
basis of channel blockade amplitude and/or residence time
when the molecule is driven through the pore. By using a
ssDNA polymer with an analyte-binding site as the sensor
molecule, the presence of an analyte molecule can be
detected through a change in DNA blockade of the
channel [59]. This presents an opportunity to use multiple
sensor molecules that can all bind in the toxin pore,
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therefore allowing for the detection of many different types
and sizes of analytes.
6. Conclusion
The application of aHL in the field of bioengineering has
been demonstrated, and the biochemical and structural
studies performed thus far greatly aid understanding of the
mode of action of the toxin. Of even greater interest is its
applicability in membrane protein-folding studies. As
described earlier, the thermodynamics of OmpA membrane
folding have been well examined. However, aHL may
prove to be a more tenable model for understanding the
mechanism of h-barrel folding in membrane bilayers. A
major difficulty, which precludes a better understanding of
insertion and folding in the membrane, is the ability to
obtain protein in the initial, intermediate, and final steps of
assembly in the membrane. As has been demonstrated
experimentally and outlined here, the model for aHL
assembly provides a framework to be used in studying the
process of folding and insertion in the membrane. Extensive
biochemical studies have identified mutants halted at inter-
mediate stages of toxin assembly, and crystallographic
studies have provided the structures of the initial and final
stages in channel formation. Future structural studies,
focused on the assembly intermediates, will provide snap-
shots of the folding pathway and provide insight into the
processes involved in the assembly and folding of h-barrel
proteins.
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